(IGSB) iShares 1-5 Year Investment - Ratings and Ratios
Corporate Bonds, Investment Grade, Short-Term
Dividends
| Dividend Yield | 4.41% |
| Yield on Cost 5y | 4.93% |
| Yield CAGR 5y | 12.37% |
| Payout Consistency | 87.4% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.79% |
| Value at Risk 5%th | 2.80% |
| Relative Tail Risk | -5.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 1.66 |
| CAGR/Max DD | 2.78 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.374 |
| Beta | 0.030 |
| Beta Downside | 0.015 |
| Drawdowns 3y | |
|---|---|
| Max DD | 2.10% |
| Mean DD | 0.36% |
| Median DD | 0.23% |
Description: IGSB iShares 1-5 Year Investment October 16, 2025
The iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) tracks an index of U.S.-dollar-denominated, investment-grade corporate bonds issued by both U.S. and non-U.S. companies. Eligible securities must trade on the U.S. domestic market, have a remaining maturity of ≥ 1 year and < 5 years, and be publicly issued. The fund is required to hold at least 80 % of its assets in the index’s component securities and at least 90 % in fixed-income securities that BFA believes will help it track the index.
As of the most recent data (Q3 2025), IGSB’s weighted-average maturity is approximately 3.2 years, and its weighted-average credit rating is A- (Moody’s A2). The ETF’s expense ratio is 0.07 %, and it is yielding around 4.2 % after taxes, reflecting the current short-term corporate credit spread environment. Its performance is highly sensitive to Federal Reserve policy moves, with a modified duration of roughly 1.5, meaning a 100 bp rise in rates would likely depress the fund’s price by about 1.5 %.
If you want a data-driven side-by-side comparison of IGSB’s risk-adjusted returns versus peers, ValueRay’s analytics dashboard offers the granular metrics you need to evaluate the trade-off.
What is the price of IGSB shares?
Over the past week, the price has changed by +0.02%, over one month by +0.31%, over three months by +0.80% and over the past year by +6.29%.
Is IGSB a buy, sell or hold?
What are the forecasts/targets for the IGSB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 57.6 | 8.9% |
IGSB Fundamental Data Overview December 09, 2025
Beta = 0.42
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 21.69b USD (21.69b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 21.69b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 21.69b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.13% (E(21.69b)/V(21.69b) * Re(6.13%) + (debt-free company))
Discount Rate = 6.13% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IGSB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle